
Effects of the H 2 -Receptor Antagonist Famotidine on the Pharmacokinetics of Atazanavir-Ritonavir With or Without Tenofovir in HIV-Infected Patients
Author(s) -
Xiaodong Wang,
Marta Boffito,
Jenny Zhang,
Ellen Chung,
Zhu Li,
YongJin Wu,
Kristine B. Patterson,
Angela D. M. Kashuba,
Pablo Tebas,
Michael Child,
Lisa Mahnke,
Richard Bertz
Publication year - 2011
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/ht4h-2688
Subject(s) - atazanavir , ritonavir , tenofovir , famotidine , pharmacology , pharmacokinetics , human immunodeficiency virus (hiv) , enfuvirtide , virology , antagonist , medicine , chemistry , viral load , antiretroviral therapy , receptor , immunology , epitope , antigen , gp41